CRISPR Therapeutics AG

NASDAQ: CRSP · Real-Time Price · USD
41.66
0.30 (0.73%)
At close: Jun 16, 2025, 3:59 PM
41.53
-0.31%
Pre-market: Jun 17, 2025, 04:38 AM EDT

CRISPR Therapeutics Revenue

CRISPR Therapeutics reported an annual revenue of $35M, reflecting a -90.57% growth. For the quarter ending March 31, 2025, CRISPR Therapeutics generated $865K in revenue.
Revenue (ttm)
$35M
Revenue Growth
-90.57%
Price / Sales Ratio
94.87
Revenue / Employee
$89.06K
Employees
393
Market Cap
3.6B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.